 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/22/2024 |
$0.50 |
$0.55 |
$0.46 |
$0.46 |
11.20K | | 04/23/2024 |
$0.46 |
$0.48 |
$0.44 |
$0.44 |
4.80K | | 04/24/2024 |
$0.43 |
$0.45 |
$0.43 |
$0.45 |
9.00K | | 04/25/2024 |
$0.43 |
$0.45 |
$0.43 |
$0.44 |
15.60K | | 04/26/2024 |
$0.46 |
$0.48 |
$0.44 |
$0.46 |
8.70K |
|
|
| Evoke Pharma is a pharmaceutical company focused primarily on the development and commercialization of drugs to treat gastrointestinal disorders and diseases. Co. is focused on developing its primary product, Gimoti (metoclopramide) nasal spray. Gimoti is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide providing delivery by nasal spray administration. Co. is party to a commercial services agreement with Eversana Life Science Services, LLC, or Eversana, pursuant to which Eversana commercializes and distributes Gimoti in the U.S. | |
|
Evoke Pharma (EVOK) has the following price history information. Looking back at EVOK historical stock prices for the last five trading days, on April 22, 2024, EVOK opened at $0.50, traded as high as $0.55 and as low as $0.46, and closed at $0.46. Trading volume was a total of 11.20K shares. On April 23, 2024, EVOK opened at $0.46, traded as high as $0.48 and as low as $0.44, and closed at $0.44. Trading volume was a total of 4.80K shares. On April 24, 2024, EVOK opened at $0.43, traded as high as $0.45 and as low as $0.43, and closed at $0.45. Trading volume was a total of 9.00K shares. On April 25, 2024, EVOK opened at $0.43, traded as high as $0.45 and as low as $0.43, and closed at $0.44. Trading volume was a total of 15.60K shares. On April 26, 2024, EVOK opened at $0.46, traded as high as $0.48 and as low as $0.44, and closed at $0.46. Trading volume was a total of 8.70K shares.
EVOK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Evoke Pharma shares, starting with a $10,000 purchase of EVOK, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/29/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$114.96 |
|
| End price/share: |
$0.46 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.60% |
|
| Average Annual Total Return: |
-42.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$39.85 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/22/2024 | $0.46 | | 04/23/2024 | $0.44 | | 04/24/2024 | $0.45 | | 04/25/2024 | $0.44 | | 04/26/2024 | $0.46 |
|
|
Free EVOK Email Alerts:
